Cognizant Shares Slide 5% Despite Q1 Earnings Beat as 'Project Leap' Costs Loom
Cognizant Technology Solutions (CTSH) reported first-quarter results on Wednesday that topped analyst estimates for both earnings and revenue, but shares tumbled more than 5% in pre-market trading. While the company raised its margin outlook and reported a surge in bookings, investors appear wary of the significant restructuring costs associated with its newly announced 'Project Leap' efficiency program.
Earnings Beat vs. Market Retreat
Cognizant reported Q1 2026 GAAP earnings of $1.39 per share, comfortably beating the consensus estimate of $1.33. Adjusted EPS reached $1.40, representing a 13.8% increase year-over-year. Revenue for the quarter came in at $5.41 billion, slightly ahead of the $5.41 billion expected by analysts and marking a 5.8% increase from the prior year.
Despite these headline beats, the stock price fell 5.08% to $51.86 in pre-market action, down from a previous close of $54.63. The sell-off suggests that the market is looking past the immediate earnings upside to focus on the costs of internal transformation and a 'complex macroeconomic environment' cited by CEO Ravi Kumar S.
'Project Leap' and the Margin Trade-Off
The primary catalyst for investor caution appears to be the unveiling of 'Project Leap.' This program is designed to streamline the company's operating model and fund investments in AI and workforce upskilling. While management expects the program to generate $200 million to $300 million in savings during 2026, it comes with a steep price tag. Cognizant expects to record restructuring charges between $230 million and $320 million, with the vast majority incurred this year.
CFO Jatin Dalal noted that these savings are already being factored into a higher margin floor. The company raised its 2026 adjusted operating margin guidance to a range of 16.0% to 16.2%, up from the previous forecast of 15.9% to 16.1%. However, the immediate impact of $200 million to $270 million in severance and personnel-related costs seems to be weighing on sentiment.
Segment Performance and AI Momentum
Operationally, Cognizant showed resilience in its core verticals. Health Sciences led the way with 9.4% reported growth, while Financial Services—a key pillar for the firm—grew 5.1%. The company also reported a 21% jump in quarterly bookings, driven by seven 'large deals' (contracts over $100 million), including one 'mega deal' exceeding $500 million.
CEO Ravi Kumar S highlighted the company's role in bridging the 'AI Velocity Gap,' helping clients turn experimental AI investments into operational outcomes. This strategy is reflected in the company's headcount growth, which rose by 21,300 year-over-year to a total of 357,600 employees, even as the company moves to optimize its workforce through Project Leap.
Forward Outlook
Cognizant maintained its full-year 2026 constant currency revenue growth guidance at 4.0% to 6.5%. While the raised margin guidance is a positive signal for long-term profitability, the pre-market reaction indicates that investors are currently prioritizing the risks of a restructuring-heavy year over the promise of AI-led efficiencies. Analysts will likely focus on the execution of Project Leap and the sustainability of the recent bookings momentum during the upcoming conference call.
Key Takeaways
- Cognizant beat Q1 EPS estimates by $0.07, reporting $1.39 GAAP EPS on revenue of $5.41 billion.
- Shares fell 5.08% in pre-market trading as investors reacted to the $230M-$320M cost of the new 'Project Leap' restructuring program.
- Management raised 2026 adjusted operating margin guidance to 16.0%-16.2%, citing expected savings from efficiency initiatives.
- Bookings grew 21% year-over-year, supported by seven large deals, signaling strong demand despite a complex macro backdrop.